Thyroid status, cardiovascular risk, and mortality in older adults

被引:611
作者
Cappola, AR
Fried, LP
Arnold, AM
Danese, MD
Kuller, LH
Burke, GL
Tracy, RP
Ladenson, PW
机构
[1] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Div Epidemiol,Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Johns Hopkins Med Inst, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Ctr Aging & Hlth, Baltimore, MD 21205 USA
[5] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[6] Outcomes Insights Inc, Newbury Pk, CA USA
[7] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA
[8] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA
[9] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
[10] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA
[11] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Baltimore, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 09期
关键词
D O I
10.1001/jama.295.9.1033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Previous studies have suggested that subclinical abnormalities in thyroid-stimulating hormone levels are associated with detrimental effects on the cardiovascular system. Objective To determine the relationship between baseline thyroid status and incident atrial fibrillation, incident cardiovascular disease, and mortality in older men and women not taking thyroid medication. Design, Setting, and Participants A total of 3233 US community-dwelling individuals aged 65 years or older with baseline serum thyroid-stimulating hormone levels were enrolled in 1989-1990 in the Cardiovascular Health Study, a large, prospective cohort study. Main Outcome Measures Incident atrial fibrillation, coronary heart disease, cerebrovascular disease, cardiovascular death, and all-cause death assessed through June 2002. Analyses are reported for 4 groups defined according to thyroid function test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism. Results Individuals with overt thyrotoxicosis ( n = 4) were excluded because of small numbers. Eighty-two percent of participants ( n = 2639) had normal thyroid function, 15% ( n = 496) had subclinical hypothyroidism, 1.6% ( n = 51) had overt hypothyroidism, and 1.5% ( n = 47) had subclinical hyperthyroidism. After exclusion of those with prevalent atrial fibrillation, individuals with subclinical hyperthyroidism had a greater incidence of atrial fibrillation compared with those with normal thyroid function ( 67 events vs 31 events per 1000 person-years; adjusted hazard ratio, 1.98; 95% confidence interval, 1.29-3.03). No differences were seen between the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease, cerebrovascular disease, cardiovascular death, or all-cause death. Likewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortality. Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 ( 95% confidence interval, 0.90-1.28) for incident coronary heart disease. Conclusion Our data show an association between subclinical hyperthyroidism and development of atrial fibrillation but do not support the hypothesis that unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other cardiovascular disorders or mortality.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 40 条
  • [1] Subclinical hyperthyroidism as a risk factor for atrial fibrillation
    Auer, J
    Scheibner, P
    Mische, T
    Langsteger, W
    Eber, O
    Eber, B
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (05) : 838 - 842
  • [2] THYROID-DYSFUNCTION IN ADULTS OVER AGE 55 YEARS - A STUDY IN AN URBAN UNITED-STATES COMMUNITY
    BAGCHI, N
    BROWN, TR
    PARISH, RF
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) : 785 - 787
  • [3] THE EFFECT OF MINOR INCREMENTS IN PLASMA THYROXINE ON HEART-RATE AND URINARY SODIUM-EXCRETION
    BELL, GM
    SAWERS, JSA
    FORFAR, JC
    DOIG, A
    TOFT, AD
    [J]. CLINICAL ENDOCRINOLOGY, 1983, 18 (05) : 511 - 516
  • [4] Screening for thyroid disease: Recommendation statement
    Berg, AO
    Allan, JD
    Frame, P
    Homer, CJ
    Johnson, MS
    Klein, JD
    Lieu, TA
    Orleans, CT
    Peipert, JF
    Pender, NJ
    Siu, AL
    Teutsch, SM
    Westhoff, C
    Woolf, SH
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 125 - 127
  • [5] Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism
    Biondi, B
    Fazio, S
    Palmieri, EA
    Carella, C
    Panza, N
    Cittadini, A
    Bonè, F
    Lombardi, G
    Saccà, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) : 2064 - 2067
  • [6] Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients
    Biondi, B
    Palmieri, EA
    Fazio, S
    Cosco, C
    Nocera, M
    Saccà, L
    Filetti, S
    Lombardi, G
    Perticone, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) : 4701 - 4705
  • [7] The Colorado thyroid disease prevalence study
    Canaris, GJ
    Manowitz, NR
    Mayor, G
    Ridgway, EC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) : 526 - 534
  • [8] Hypothyroidism and atherosclerosis
    Cappola, AR
    Ladenson, PW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2438 - 2444
  • [9] The treatment of subclinical hypothyroidism is seldom necessary
    Chu, JW
    Crapo, LM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) : 4591 - 4599
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497